Clinical Trial

Indocyanine Green Tracer Using in Laparoscopic Distal Gastrectomy for Early Gastric Cancer

Unknown Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2021 (before its estimated July 2023 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the value of indocyanine green (ICG) in laparoscopic distal gastrectomy with lymph node dissection for early gastric cancer.The patients with early gastric adenocarcinoma (cT1, N-/+, M0) will be studied.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT04973475
Lead Sponsor Fujian Medical University
Conditions Early Gastric Cancer, Indocyanine Green, Lymph Node Dissection
Enrollment 180 participants
Start Date 2021-07
Primary Completion 2023-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2021-07-22